U.S. Markets closed

Exelixis, Inc. (EXEL)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
26.33-0.55 (-2.05%)
At close: 4:00PM EDT
People also watch
ARRYIMGNINCYCLDXSGEN
  • C
    Cosmo
    Cosmo
    Johnonymous, you leave me no choice. One more post from either you or yourself and mark my words I will blot out the sun on Monday leaving all of North America shrouded in darkness for about 2 hours!
  • J
    John Dsouza
    John Dsouza
    Probably last best chance to cover under $27 shorties (consider it a gift)!
  • M
    Marlon
    Marlon
    Anyone knows how long FDA has to respond to the sNDA filed by EXEL today? Or there is no deadline at all? Thanks
  • A
    Anonymous
    Anonymous
    Can anyone tell me why this stick isnt $40 by now??? They are debt free and doing everything right and it just sits around $26-28!!! This is also a great buyout candidate. I just don't understand it..
  • t
    tim
    tim
    NDA submission for 1st line RCC! Timing is impeccable, considering the BMY results yesterday.
  • B
    Biogemfinder
    Biogemfinder
    Very typical sell the news crowd is at work again. But you know how it end in the longer term -- say 3 days later? I now fully expect the PPS of EXEL to be above $30 mark before the next earnings. If there is positive data on HCC likely $35 before the earnings. Of course there is the possibility of good BO offer (which I personally dont prefer), or the market meltdown related to political upheaval.
  • A
    Anonymous
    Anonymous
    Nasdaq has a paltry 28.50 PT on EXEL which indicates that the shares are currently fully valued. Buy TZA... because the selling will continue for the next few weeks.....🐻
  • J
    John
    John
    In case you Dudes haven't noticed the PPS is going down not up.
  • r
    rtr
    rtr
    I see most people haven't figured it out yet.........Topline results released Tuesday from Bristol-Myers Squibb Co. (BMY) shows that the combination of two Bristol-Myers drugs, Opdivo and Yervoy, failed to show a statistically significant improvement over Pfizer's (PFE) Sutent in intermediate- and poor-risk kidney cancer patients. That's good news for Exelixis because previously released results already showed improvement from use of Cabometyx over Sutent in an identical sample of kidney cancer patients.
  • J
    John Dsouza
    John Dsouza
    Have that funny feeling in the bones that some NEWS is coming from EXEL very soon (and I don't mean BO news but rather data or FDA related)!
  • a
    antonio
    antonio
    please someone tell me what is going on with exel dropping..?
  • S
    Siavash Nikkhou
    Siavash Nikkhou
    $30 next week
  • N
    Neil
    Neil
    EXEL up AH. I suspect the BM Kidney trial failure (opdivo and Yuervoy combo) didn't beat sunitinib, has folks thinking that the path may be clearing for Cabo in this indication? Anyone else agree?
  • s
    socialidiocies
    socialidiocies

    NEWS FLASH!!!! All CS-3150 trials are registered as completed! Last ones Updated aug 10.

    https://clinicaltrials.gov/ct2/results?cond=&term=cs-3150&cntry1=&state1=&recrs=

    Search of: ALL - List Results - ClinicalTrials.gov
    clinicaltrials.gov
  • m
    misha12345
    misha12345
    what happen? pulling back to red.
  • J
    John Dsouza
    John Dsouza
    So John then why don't you short EXEL and let us all know that you did so we can come back to you in a few weeks/months and tell you how much you've lost. You know we're all long do you have the guts to admit that you're short and that your current short position is already way underwater. Time to cover bro and minimize your loss!
  • p
    paul
    paul
    Double catalysts this am!! New FDA Filing and Big FLOP for BMY. CHEERS TO ALL LONGS!!🍻🍻
  • H
    Howard
    Howard
    Why is this down with all the good news? This should be sky rocketing.
  • J
    John Dsouza
    John Dsouza
    Well that didn't take long for my gut feeling from yesterday to come true! :-) Believe me if I was really that good I'd be in a casino on a daily basis!! On second thought I guess the stock market is the same as a casino just with better odds especially when you have a great company like EXEL to invest in!!! Here's to $30+ very soon and much higher going forward....
  • H
    Hairy G. Balls
    Hairy G. Balls
    Fella ... ready to reject a $40 bid, ok, ya hear me? REJECT $40 ... say hell no! $70 or go home!